<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">asurgery</journal-id><journal-title-group><journal-title xml:lang="ru">Амбулаторная хирургия</journal-title><trans-title-group xml:lang="en"><trans-title>Ambulatornaya khirurgiya = Ambulatory Surgery (Russia)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2712-8741</issn><issn pub-type="epub">2782-2591</issn><publisher><publisher-name>ООО «ГРУППА РЕМЕДИУМ»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21518/1995-14772018-1-2-14-19</article-id><article-id custom-type="elpub" pub-id-type="custom">asurgery-103</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>АКТУАЛЬНО</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>TOPICAL ISSUES</subject></subj-group></article-categories><title-group><article-title>Консервативное лечение хронических облитерирующих заболеваний артерий нижних конечностей</article-title><trans-title-group xml:lang="en"><trans-title>Conservative treatment of chronic obliterating diseases of lower limb arteries</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Богачев</surname><given-names>В. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Bogachev</surname><given-names>V. YU.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Болдин</surname><given-names>Б. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Boldin</surname><given-names>B. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Родионов</surname><given-names>С. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Rodionov</surname><given-names>S. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Туркин</surname><given-names>П. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Turkin</surname><given-names>P. YU.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Российский национальный исследовательский медицинский университет им. Н.И. Пирогова</institution><country>Россия</country></aff><aff xml:lang="en"><institution>N.I.Pirogov Russian National Research Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2018</year></pub-date><pub-date pub-type="epub"><day>20</day><month>06</month><year>2018</year></pub-date><volume>0</volume><issue>1-2</issue><fpage>14</fpage><lpage>19</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Богачев В.Ю., Болдин Б.В., Родионов С.В., Туркин П.Ю., 2018</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="ru">Богачев В.Ю., Болдин Б.В., Родионов С.В., Туркин П.Ю.</copyright-holder><copyright-holder xml:lang="en">Bogachev V.Y., Boldin B.V., Rodionov S.V., Turkin P.Y.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.a-surgeon.ru/jour/article/view/103">https://www.a-surgeon.ru/jour/article/view/103</self-uri><abstract><p>Общая распространенность атеросклероза периферических артерий варьирует в пределах 3-10%, возрастая до 15-20% среди больных старше 70 лет. Хронические облитерирующие заболевания артерий нижних конечностей (ХОЗАНК) в силу высокой и постоянно увеличивающейся распространенности представляют собой важную как медицинскую, так и социально-экономическую проблему, которую невозможно решить лишь широким внедрением и применением разнообразных инновационных хирургических технологий. Дело в том, что даже самые современные и наукоемкие оперативные вмешательства не оказывают принципиального влияния на основы патогенеза ХОЗАНК. Более того, не вызывает сомнений, что успех артериальной реконструкции и его пролонгация во многом определяются адекватным консервативным лечением, принципы которого и обсуждаются в данной публикации.</p></abstract><trans-abstract xml:lang="en"><p>The incidence of peripheral arteries atherosclerosis varies in the general population between 3 to 10%, increasing to 15 to 20% in patients older than 70 years. Due to the high and constantly increasing prevalence, chronic obliterating diseases of lower limbs arteries (CODLLA) constitute an important medical and socioeconomic problem that cannot be solved only through wide introduction and application of various innovative surgical technologies. The fact is that even the most modern and knowledge-intensive surgical interventions do not exert a fundamental influence on the principles of the CODLLA pathogenesis. Moreover, there is no doubt that the success of arterial reconstruction and its prolongation are largely determined by adequate conservative treatment, the principles of which are discussed in this article.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>атеросклероз периферических артерий</kwd><kwd>хронические облитерирующие заболевания артерий нижних конечностей (ХОЗАНК)</kwd><kwd>консервативная терапия</kwd><kwd>atherosclerosis of peripheral arteries</kwd><kwd>chronic obliterating diseases of lower limbs arteries (CODLLA)</kwd><kwd>conservative therapy</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg, 2018: 1-64. In press.</mixed-citation><mixed-citation xml:lang="en">ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg, 2018: 1-64. In press.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Dormandy J, Nehler M, Harris K, Fowkes F on behalf of the TASC II Working Group Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg, 2007, 33(Suppl 1).</mixed-citation><mixed-citation xml:lang="en">Dormandy J, Nehler M, Harris K, Fowkes F on behalf of the TASC II Working Group Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg, 2007, 33(Suppl 1).</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Porter JM, Cutler BS, Lee BY et al. Pentoxifylline efficacy in the treatment of intermittent claudication: multicenter controlled double-blind trial with objective assessment of chronic occlusive arterial disease patients. Am Heart J, 1982, 104: 66-72.</mixed-citation><mixed-citation xml:lang="en">Porter JM, Cutler BS, Lee BY et al. Pentoxifylline efficacy in the treatment of intermittent claudication: multicenter controlled double-blind trial with objective assessment of chronic occlusive arterial disease patients. Am Heart J, 1982, 104: 66-72.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Di Perri T, Guerrini M. Placebo controlled double blind study with pentoxifylline of walking performance in patients with intermittent claudication. Angiology, 1983, 34: 40-45.</mixed-citation><mixed-citation xml:lang="en">Di Perri T, Guerrini M. Placebo controlled double blind study with pentoxifylline of walking performance in patients with intermittent claudication. Angiology, 1983, 34: 40-45.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Таричко Ю.В., Зудин А.М., Учкин И.Г., Талов Н.А., Хмырова А.В. Опыт применения пентоксифиллина пролонгированного действия в комплексном лечении трофических дефектов тканей при критической ишемии нижних конечностей. Фарматека, 2011, 10: 66-69./ Tarichko YuV, Zudin AM, Uchkin IG, Talov NA, Khmyrova AV. Experience in using sustained action pentoxifylline in the combination treatment of trophic tissue defects in criticallowerlimb ischemia. Farmateka, 2011, 10: 66-69.</mixed-citation><mixed-citation xml:lang="en">Таричко Ю.В., Зудин А.М., Учкин И.Г., Талов Н.А., Хмырова А.В. Опыт применения пентоксифиллина пролонгированного действия в комплексном лечении трофических дефектов тканей при критической ишемии нижних конечностей. Фарматека, 2011, 10: 66-69./ Tarichko YuV, Zudin AM, Uchkin IG, Talov NA, Khmyrova AV. Experience in using sustained action pentoxifylline in the combination treatment of trophic tissue defects in criticallowerlimb ischemia. Farmateka, 2011, 10: 66-69.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
